Prana, PNG Settle Suit Over Patent For Alzheimer Biotech Drug
As part of the settlement, Prana and P.N.G. have agreed to recognize the rights of each other to develop clioquinol in their respective territories. Prana will hold the rights to clioquinol in the U.S. and Japan, while P.N.G. will hold the rights for European and other
Territories, the companies said.
Prana said it...
To view the full article, register now.